Avista Acquisition Corp. 4
4 · Organogenesis Holdings Inc. · Filed Dec 12, 2018
Insider Transaction Report
Form 4
Avista Acquisition Corp.
10% Owner
Transactions
- Other
Class B Ordinary Shares
2018-12-10−3,247,668→ 1,048,691 total→ Class A Ordinary Shares (3,247,668 underlying)
Footnotes (5)
- [F1]Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of Avista Healthcare Public Acquisition Corp. (the "Issuer"), the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date.
- [F2]The 3,247,668 Class B ordinary shares were forfeited by Avista Acquisition Corp. (the "Sponsor") to the Issuer for no consideration prior to the closing of the Business Combination.
- [F3]Directly owned by Sponsor. The sole shareholder of Sponsor is Avista Acquisition, LLC ("Avista Acquisition" and, together with Sponsor, the "Reporting Persons").
- [F4]Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- [F5]Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.